Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy

Total article views   HTML views PDF downloads Totals
7,765 Dovepress* 7,765+ 2,633 10,398
Totals 7,765 2,633 10,398
*Since 23 October 2012
+Since July 2016

View citations on Google Scholar